These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9737644)

  • 21. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia.
    Simons LA
    Am J Cardiol; 2002 Oct; 90(7):737-40. PubMed ID: 12356387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
    Hunninghake D; Insull W; Knopp R; Davidson M; Lohrbauer L; Jones P; Kafonek S
    Am J Cardiol; 2001 Sep; 88(6):635-9. PubMed ID: 11564386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of cerivastatin in primary hypercholesterolemia: a long term comparative titration study with simvastatin.
    Leiter LA; Hanna K
    Can J Cardiol; 1999 May; 15(5):545-55. PubMed ID: 10350664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia.
    Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
    Clin Ther; 1998; 20(3):539-48. PubMed ID: 9663369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerivastatin for lowering lipids.
    Adams SP; Tiellet N; Alaeiilkhchi N; Wright JM
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012501. PubMed ID: 31981471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group.
    Lambrecht LJ; Malini PL
    Acta Cardiol; 1993; 48(6):541-54. PubMed ID: 8122478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group.
    Ose L; Luurila O; Eriksson J; Olsson A; Lithell H; Widgren B
    Curr Med Res Opin; 1999; 15(3):228-40. PubMed ID: 10621930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor.
    Stein EA
    Drugs; 1998; 56 Suppl 1():25-31; discussion 33. PubMed ID: 9740538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study.
    Hanefeld M; Deslypere JP; Ose L; Durrington PN; Farnier M; Schmage N
    J Int Med Res; 1999; 27(3):115-29. PubMed ID: 10505301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
    Zachoval R; Gerbes AL; Schwandt P; Parhofer KG
    J Hepatol; 2001 Jul; 35(1):86-91. PubMed ID: 11495047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.
    Welty FK; Lewis SJ; Friday KE; Cain VA; Anzalone DA
    J Womens Health (Larchmt); 2016 Jan; 25(1):50-6. PubMed ID: 26539650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
    Steinhagen-Thiessen E
    Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies.
    Wierzbicki AS; Mikhailidis DP
    Int J Cardiol; 2002 Jul; 84(1):53-7. PubMed ID: 12104065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of statins in hypertriglyceridemia.
    Stein EA; Lane M; Laskarzewski P
    Am J Cardiol; 1998 Feb; 81(4A):66B-69B. PubMed ID: 9526817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.